ARTICLE | Analyst Picks & Changes
Analyst picks & changes
January 16, 1995 8:00 AM UTC
Edward Hurwitz of Robertson Stephens initiated coverage of Agouron Pharmaceuticals Inc. with a "buy" in anticipation of mounting enthusiasm for HIV protease inhibitors, including AGPH's AG1343. The company will report Phase I data at the end of this month and pilot Phase II data by mid-year. AGPH has said that the human data thus far looks better than its animal data. ...